Previous 10 | Next 10 |
NanoViricides ( NYSE: NNVC ) FQ1 net loss narrowed to -$1.57M, compared to -$2.61M in the prior year period. The company said that it has sufficient funds to complete initial human clinical trials of its lead drug candidate NV-CoV-2 to treat COVID-19 and long COVID. ...
SHELTON, CT / ACCESSWIRE / November 15, 2022 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2022 with the Securities and Exchange Commission (SEC) on Monday, November ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero. However, that risk is even higher with speculative penny stocks. At the same, these less-established fir...
--News Direct-- Learn more about NanoViricides, Inc. by gaining access to the latest research report New York City is investigating the cause of death for two people who died after contracting monkeypox. Though both of the deceased had higher fatality ris...
SHELTON, CT / ACCESSWIRE / October 14, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2022 with the Securities and Exchange Commission (SEC) on Thursday, October 13, 2022. The rep...
NanoViricides ( NYSE: NNVC ) reported that its optimistic it can speed up the process to move drug development of NV-387-T, its monkeypox drug candidate into human clinical trials quickly. The active ingredient tecovirimat has already been approved by the Food and Drug Adminis...
--News Direct-- Learn More about NanoViricides, Inc. by gaining access to the latest research report As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease. Since the first reports of monkeypox infection in the United State...
(NewsDirect) https://profiles.smallcapsdaily.com/nnvc/ More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are still small scientists are now concerned that this sudden and unusual outbreak could lea...
--News Direct-- https://profiles.smallcapsdaily.com/nnvc/ More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are still small scientists are now concerned that this sudden and unusual outbreak could ...
SHELTON, CT / ACCESSWIRE / August 9, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, provides further details on its rapid drug development strategy for Monk...
News, Short Squeeze, Breakout and More Instantly...
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...
SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.: NNVC ) (the "Company"), a clinical stage company and global leader in broad-spectrum antiviral nanomedicines, reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was foun...
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...